sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
2020-2025 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

2020-2025 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market...

Home / Categories / Information & Communications Technology
2020-2025 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
2020-2025 Global Pharmaceutical Contract Development...
Report Code
RO9/125/31846

Publish Date
04/Mar/2021

Pages
101
PRICE
$ 3360/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5040/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 6720/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table of Content

1 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer

3 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forces
3.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - By Geography
4.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Value and Market Share by Regions
4.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value ($) by Region (2015-2020)
4.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value Market Share by Regions (2015-2020)
4.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Production and Market Share by Major Countries
4.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production by Major Countries (2015-2020)
4.2.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production Market Share by Major Countries (2015-2020)
4.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Market Share by Regions
4.3.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Regions (2015-2020)
4.3.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Regions (2015-2020)

5 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - By Trade Statistics
5.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import
5.2 United States Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
5.3 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
5.4 China Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
5.5 Japan Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
5.6 India Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
5.7 ...

6 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - By Type
6.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production and Market Share by Types (2015-2020)
6.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production by Types (2015-2020)
6.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production Market Share by Types (2015-2020)
6.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value and Market Share by Types (2015-2020)
6.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value by Types (2015-2020)
6.2.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value Market Share by Types (2015-2020)
6.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production, Price and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2015-2020)
6.4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production, Price and Growth Rate of Finished Dosage Formulation (FDF) Development (2015-2020)
6.5 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production, Price and Growth Rate of and Manufacturing (2015-2020)
6.6 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production, Price and Growth Rate of Secondary Packaging (2015-2020)

7 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - By Application
7.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Applications (2015-2020)
7.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Applications (2015-2020)
7.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate of Preclinical (2015-2020)
7.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate of Phase I (2015-2020)
7.4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate of Phase II (2015-2020)
7.5 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate of Phase III (2015-2020)
7.6 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate of Phase IV (2015-2020)

8 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market
8.1 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
8.2 United States Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
8.3 Canada Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
8.4 Mexico Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
8.5 The Influence of COVID-19 on North America Market

9 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis
9.1 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.2 Germany Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.3 United Kingdom Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.4 France Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.5 Italy Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.6 Spain Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.7 The Influence of COVID-19 on Europe Market

10 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis
10.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.2 China Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.3 Japan Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.4 South Korea Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.5 Southeast Asia Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.6 India Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis
11.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
11.2 Saudi Arabia Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
11.3 UAE Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
11.4 South Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis
12.1 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
12.2 Brazil Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
12.3 The Influence of COVID-19 on South America Market

13 Company Profiles
13.1 Famar SA
13.1.1 Famar SA Basic Information
13.1.2 Famar SA Product Profiles, Application and Specification
13.1.3 Famar SA Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.2 Covance Inc.
13.2.1 Covance Inc. Basic Information
13.2.2 Covance Inc. Product Profiles, Application and Specification
13.2.3 Covance Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.3 Boehringer Ingelheim Group
13.3.1 Boehringer Ingelheim Group Basic Information
13.3.2 Boehringer Ingelheim Group Product Profiles, Application and Specification
13.3.3 Boehringer Ingelheim Group Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.4 PAREXEL International Corporation
13.4.1 PAREXEL International Corporation Basic Information
13.4.2 PAREXEL International Corporation Product Profiles, Application and Specification
13.4.3 PAREXEL International Corporation Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.5 Aenova Holding GmbH
13.5.1 Aenova Holding GmbH Basic Information
13.5.2 Aenova Holding GmbH Product Profiles, Application and Specification
13.5.3 Aenova Holding GmbH Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.6 Lonza Group
13.6.1 Lonza Group Basic Information
13.6.2 Lonza Group Product Profiles, Application and Specification
13.6.3 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.7 Baxter Biopharma Solutions
13.7.1 Baxter Biopharma Solutions Basic Information
13.7.2 Baxter Biopharma Solutions Product Profiles, Application and Specification
13.7.3 Baxter Biopharma Solutions Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.8 Jubilant Life Sciences Ltd.
13.8.1 Jubilant Life Sciences Ltd. Basic Information
13.8.2 Jubilant Life Sciences Ltd. Product Profiles, Application and Specification
13.8.3 Jubilant Life Sciences Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.9 Novotech Pty Ltd.
13.9.1 Novotech Pty Ltd. Basic Information
13.9.2 Novotech Pty Ltd. Product Profiles, Application and Specification
13.9.3 Novotech Pty Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.10 Syneos Health Inc.
13.10.1 Syneos Health Inc. Basic Information
13.10.2 Syneos Health Inc. Product Profiles, Application and Specification
13.10.3 Syneos Health Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.11 LSK Global Pharma Service Co Ltd.
13.11.1 LSK Global Pharma Service Co Ltd. Basic Information
13.11.2 LSK Global Pharma Service Co Ltd. Product Profiles, Application and Specification
13.11.3 LSK Global Pharma Service Co Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.12 Catalent Inc.
13.12.1 Catalent Inc. Basic Information
13.12.2 Catalent Inc. Product Profiles, Application and Specification
13.12.3 Catalent Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.13 Patheon Inc.
13.13.1 Patheon Inc. Basic Information
13.13.2 Patheon Inc. Product Profiles, Application and Specification
13.13.3 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.14 Pfizer CentreSource
13.14.1 Pfizer CentreSource Basic Information
13.14.2 Pfizer CentreSource Product Profiles, Application and Specification
13.14.3 Pfizer CentreSource Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.15 CMIC Holdings Co. Ltd
13.15.1 CMIC Holdings Co. Ltd Basic Information
13.15.2 CMIC Holdings Co. Ltd Product Profiles, Application and Specification
13.15.3 CMIC Holdings Co. Ltd Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.16 Pharmaceutical Product Development LLC
13.16.1 Pharmaceutical Product Development LLC Basic Information
13.16.2 Pharmaceutical Product Development LLC Product Profiles, Application and Specification
13.16.3 Pharmaceutical Product Development LLC Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.17 Recipharm AB
13.17.1 Recipharm AB Basic Information
13.17.2 Recipharm AB Product Profiles, Application and Specification
13.17.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)

14 Market Forecast - By Regions
14.1 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast (2020-2025)
14.2 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast (2020-2025)
14.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast (2020-2025)
14.4 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast (2020-2025)
14.5 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast (2020-2025)

15 Market Forecast - By Type and Applications
15.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast by Types (2020-2025)
15.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast by Applications (2020-2025)

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com